1. Home
  2. DNA vs GMRE Comparison

DNA vs GMRE Comparison

Compare DNA & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • GMRE
  • Stock Information
  • Founded
  • DNA 2008
  • GMRE 2011
  • Country
  • DNA United States
  • GMRE United States
  • Employees
  • DNA N/A
  • GMRE N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • GMRE Real Estate Investment Trusts
  • Sector
  • DNA Health Care
  • GMRE Real Estate
  • Exchange
  • DNA Nasdaq
  • GMRE Nasdaq
  • Market Cap
  • DNA 466.4M
  • GMRE 485.5M
  • IPO Year
  • DNA N/A
  • GMRE N/A
  • Fundamental
  • Price
  • DNA $8.57
  • GMRE $6.19
  • Analyst Decision
  • DNA Sell
  • GMRE Buy
  • Analyst Count
  • DNA 3
  • GMRE 3
  • Target Price
  • DNA $9.67
  • GMRE $10.38
  • AVG Volume (30 Days)
  • DNA 1.1M
  • GMRE 699.2K
  • Earning Date
  • DNA 08-07-2025
  • GMRE 08-05-2025
  • Dividend Yield
  • DNA N/A
  • GMRE 12.60%
  • EPS Growth
  • DNA N/A
  • GMRE N/A
  • EPS
  • DNA N/A
  • GMRE 0.03
  • Revenue
  • DNA $237,417,000.00
  • GMRE $138,220,000.00
  • Revenue This Year
  • DNA N/A
  • GMRE $4.64
  • Revenue Next Year
  • DNA $15.81
  • GMRE $3.78
  • P/E Ratio
  • DNA N/A
  • GMRE $193.38
  • Revenue Growth
  • DNA 13.76
  • GMRE N/A
  • 52 Week Low
  • DNA $5.00
  • GMRE $6.06
  • 52 Week High
  • DNA $18.40
  • GMRE $10.46
  • Technical
  • Relative Strength Index (RSI)
  • DNA 55.25
  • GMRE 35.73
  • Support Level
  • DNA $7.14
  • GMRE $6.17
  • Resistance Level
  • DNA $10.02
  • GMRE $6.38
  • Average True Range (ATR)
  • DNA 0.61
  • GMRE 0.14
  • MACD
  • DNA 0.07
  • GMRE 0.04
  • Stochastic Oscillator
  • DNA 53.53
  • GMRE 9.86

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About GMRE Global Medical REIT Inc.

Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

Share on Social Networks: